About Us
Leadership
Board of Directors
Advisors
Science
Pipeline
Ophthalmology
Metabolic Disease
Neurology
Ophthalmology
Metabolic Disease
Neurology
What We Do
Product Design
Research & Development
Manufacturing
Manufacturing
Product Design
Research & Development
News
Careers
News
Search
Search
January 8, 2024
Kriya Provides Update on Pipeline Progress Ahead of Company Presentation at 42nd Annual J.P. Morgan Healthcare Conference
: Kriya Provides Update on Pipeline Progress Ahead of Company Presentation at 42nd Annual J.P. Morgan Healthcare Conference
January 5, 2024
Kriya Announces Gene Therapy Program for Thyroid Eye Disease
: Kriya Announces Gene Therapy Program for Thyroid Eye Disease
December 20, 2023
Kriya to Present at the J.P. Morgan 42nd Annual Healthcare Conference
: Kriya to Present at the J.P. Morgan 42nd Annual Healthcare Conference
September 27, 2023
Kriya Announces Exclusive License and Collaboration Agreement with Everads to Advance Gene Therapies for Prevalent Diseases in Ophthalmology Including Geographic Atrophy
: Kriya Announces Exclusive License and Collaboration Agreement with Everads to Advance Gene Therapies for Prevalent Diseases in Ophthalmology Including Geographic Atrophy
September 6, 2023
Kriya Acquires Tramontane Therapeutics and Launches Gene Therapy Program for Nonalcoholic Steatohepatitis (NASH) and Other Prevalent Diseases
: Kriya Acquires Tramontane Therapeutics and Launches Gene Therapy Program for Nonalcoholic Steatohepatitis (NASH) and Other Prevalent Diseases
July 26, 2023
Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases
: Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases
May 2, 2023
Kriya to Present 10 Abstracts at the 2023 American Society of Gene and Cell Therapy Annual Meeting
: Kriya to Present 10 Abstracts at the 2023 American Society of Gene and Cell Therapy Annual Meeting
November 16, 2022
Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio
: Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio
August 25, 2022
Kriya Appoints Curt Herberts as President and Chief Operating Officer
: Kriya Appoints Curt Herberts as President and Chief Operating Officer
Previous
1
2
3
Load More
Team
Pipeline
Ophthalmology
Metabolic Disease
Neurology
Platform
Manufacturing
Product Design
Research & Development
News
Careers
